sc-PDB: a 3D-database of ligandable binding sites—10 years on
暂无分享,去创建一个
Didier Rognan | Guillaume Bret | Esther Kellenberger | Jérémy Desaphy | E. Kellenberger | G. Bret | D. Rognan | Jérémy Desaphy
[1] W. L. Jorgensen,et al. Energetics of displacing water molecules from protein binding sites: consequences for ligand optimization. , 2009, Journal of the American Chemical Society.
[2] Ruben Abagyan,et al. Pocketome: an encyclopedia of small-molecule binding sites in 4D , 2011, Nucleic Acids Res..
[3] Themis Lazaridis,et al. Water at biomolecular binding interfaces. , 2007, Physical chemistry chemical physics : PCCP.
[4] T. N. Bhat,et al. The PDB data uniformity project , 2001, Nucleic Acids Res..
[5] J. Peters. Polypharmacology - foe or friend? , 2013, Journal of medicinal chemistry.
[6] Alfonso Valencia,et al. FireDB: a compendium of biological and pharmacologically relevant ligands , 2013, Nucleic Acids Res..
[7] Haruki Nakamura,et al. The worldwide Protein Data Bank (wwPDB): ensuring a single, uniform archive of PDB data , 2006, Nucleic Acids Res..
[8] María Martín,et al. Activities at the Universal Protein Resource (UniProt) , 2013, Nucleic Acids Res..
[9] Didier Rognan,et al. sc-PDB: a database for identifying variations and multiplicity of 'druggable' binding sites in proteins , 2011, Bioinform..
[10] Matthias Rarey,et al. Protoss: a holistic approach to predict tautomers and protonation states in protein-ligand complexes , 2014, Journal of Cheminformatics.
[11] J. Ladbury. Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design. , 1996, Chemistry & biology.
[12] Jan M. Kriegl,et al. Form follows function: Shape analysis of protein cavities for receptor‐based drug design , 2009, Proteomics.
[13] Rutger H A Folmer,et al. Fragment screening to predict druggability (ligandability) and lead discovery success. , 2011, Drug discovery today.
[14] Didier Rognan,et al. Comparison and Druggability Prediction of Protein-Ligand Binding Sites from Pharmacophore-Annotated Cavity Shapes , 2012, J. Chem. Inf. Model..
[15] Didier Rognan,et al. Encoding Protein-Ligand Interaction Patterns in Fingerprints and Graphs , 2013, J. Chem. Inf. Model..
[16] Brian K. Shoichet,et al. Roles for Ordered and Bulk Solvent in Ligand Recognition and Docking in Two Related Cavities , 2013, PloS one.
[17] Didier Rognan,et al. sc-PDB: an Annotated Database of Druggable Binding Sites from the Protein Data Bank , 2006, J. Chem. Inf. Model..
[18] A. Hopkins,et al. The druggable genome , 2002, Nature Reviews Drug Discovery.
[19] Michael J Hartshorn,et al. AstexViewer: a visualisation aid for structure-based drug design. , 2002, Journal of computer-aided molecular design.
[20] Jonathan Weiss,et al. Development of a Rule-Based Method for the Assessment of Protein Druggability , 2012, J. Chem. Inf. Model..
[21] Motonori Ota,et al. PSCDB: a database for protein structural change upon ligand binding , 2011, Nucleic Acids Res..
[22] Sameer Velankar,et al. PDBe: Protein Data Bank in Europe , 2010, Nucleic Acids Res..
[23] Stefan Schmitt,et al. DrugPred: A Structure-Based Approach To Predict Protein Druggability Developed Using an Extensive Nonredundant Data Set , 2011, J. Chem. Inf. Model..
[24] Sameer Velankar,et al. PDBe: Protein Data Bank in Europe , 2009, Nucleic Acids Res..
[25] Michael J. Hartshorn,et al. AstexViewerTM †: a visualisation aid for structure-based drug design , 2002, J. Comput. Aided Mol. Des..
[26] J. Bajorath,et al. Polypharmacology: challenges and opportunities in drug discovery. , 2014, Journal of medicinal chemistry.
[27] J. Bajorath,et al. Quo vadis, virtual screening? A comprehensive survey of prospective applications. , 2010, Journal of medicinal chemistry.